These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Activation of NK cell cytotoxicity by aerosolized CpG-ODN/poly(I:C) against lung melanoma metastases is mediated by alveolar macrophages. Sommariva M; Le Noci V; Storti C; Bianchi F; Tagliabue E; Balsari A; Sfondrini L Cell Immunol; 2017 Mar; 313():52-58. PubMed ID: 28089340 [TBL] [Abstract][Full Text] [Related]
7. [Activity of alveolar macrophages of experimental lung cancer and inhibition of cell proliferation]. Shen BH; He MC Zhonghua Bing Li Xue Za Zhi; 1990 Dec; 19(4):279-81. PubMed ID: 2081352 [TBL] [Abstract][Full Text] [Related]
8. The pulmonary alveolar macrophage and lung cancer. Gonzalez-Rothi RJ Cancer Invest; 1987; 5(4):339-44. PubMed ID: 3311313 [No Abstract] [Full Text] [Related]
10. Antigen expression of alveolar macrophages in smokers and patients with lung diseases. Athanassiadou PP; Athanassiades PH; Kostopoulos C; Kyrkou K; Petrakakou E; Veroni S Diagn Cytopathol; 1995 Feb; 12(1):37-41. PubMed ID: 7789244 [TBL] [Abstract][Full Text] [Related]
11. [Cytostatic and growth-stimulating effects of alveolar macrophages of rats on tumor cells]. Hu LP; Gong YF; Wu DC Shi Yan Sheng Wu Xue Bao; 1990 Jun; 23(2):213-7. PubMed ID: 2375208 [TBL] [Abstract][Full Text] [Related]
12. [Immunological status of alveolar macrophages in patients with lung cancer and benign pulmonary diseases]. Liu C Zhonghua Yi Xue Za Zhi; 1992 Jul; 72(7):408-11, 446. PubMed ID: 1330230 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of tumoricidal activity of alveolar macrophages via CD40-CD40 ligand interaction. Imaizumi K; Kawabe T; Ichiyama S; Kikutani H; Yagita H; Shimokata K; Hasegawa Y Am J Physiol; 1999 Jul; 277(1):L49-57. PubMed ID: 10409230 [TBL] [Abstract][Full Text] [Related]
14. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression. Kataki A; Scheid P; Piet M; Marie B; Martinet N; Martinet Y; Vignaud JM J Lab Clin Med; 2002 Nov; 140(5):320-8. PubMed ID: 12434133 [TBL] [Abstract][Full Text] [Related]
15. Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages. Wang DH; Lee HS; Yoon D; Berry G; Wheeler TM; Sugarbaker DJ; Kheradmand F; Engleman E; Burt BM Clin Cancer Res; 2017 Feb; 23(3):778-788. PubMed ID: 27496865 [TBL] [Abstract][Full Text] [Related]
16. Alveolar macrophage function before and during treatment with cytotoxic chemotherapy in patients with small cell lung cancer. Hosker HS; McArdle P; Corris PA Eur J Cancer; 1991; 27(12):1711. PubMed ID: 1664223 [No Abstract] [Full Text] [Related]
17. Cytotoxic activity of human pulmonary alveolar macrophages. Kan-Mitchell J; Hengst JC; Kempf RA; Rothbart RK; Simons SM; Brooker AS; Kortes VL; Mitchell MS Cancer Res; 1985 Jan; 45(1):453-8. PubMed ID: 3965151 [TBL] [Abstract][Full Text] [Related]
18. NLRP3/Caspase-1 inflammasome activation is decreased in alveolar macrophages in patients with lung cancer. Lasithiotaki I; Tsitoura E; Samara KD; Trachalaki A; Charalambous I; Tzanakis N; Antoniou KM PLoS One; 2018; 13(10):e0205242. PubMed ID: 30365491 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of candidacidal activity of polymorphonuclear cells by alveolar macrophage-derived factor from lung cancer patients. Vecchiarelli A; Dottorini M; Beccari T; Cociani C; Todisco T; Bistoni F Am Rev Respir Dis; 1993 Feb; 147(2):414-9. PubMed ID: 8381631 [TBL] [Abstract][Full Text] [Related]
20. Chronic NF-κB activation links COPD and lung cancer through generation of an immunosuppressive microenvironment in the lungs. Zaynagetdinov R; Sherrill TP; Gleaves LA; Hunt P; Han W; McLoed AG; Saxon JA; Tanjore H; Gulleman PM; Young LR; Blackwell TS Oncotarget; 2016 Feb; 7(5):5470-82. PubMed ID: 26756215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]